Schedule 13G ownership disclosure

CUE BIOPHARMA INC

Security class unavailable · CUSIP: 22978P106

Event date: 2022-12-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
93,297
Percent of class
0.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-124192
Form type
SC 13G/A
Filer
Cue Biopharma, Inc.
CIK
CIK 1645460
Filed
Dec 02, 2022
Reporting period
Dec 01, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub